Client News

Galimedix Therapeutics Publishes New Data in Peer-Reviewed International Journal of Molecular Sciences Demonstrating Disease-Modifying Capability of GAL-201 in Alzheimer’s Disease

Mallia Therapeutics Reports on Novel Therapeutic Approach for Treating Alopecia at the Annual Meeting of the European Hair Research Society (EHRS)

ReproNovo Raises $65 Million Series A Financing to Advance Phase 2 Clinical Trials of Novel Therapies in Reproductive Medicine and Women’s Health

Philikos Announces Initiation of Clinical Phase 1/2 Study with T-Guard® in Patients with Systemic Sclerosis

Journal of Critical Care Publishes Positive Results from Prespecified, Biomarker-guided Subgroup Analysis of AdrenoMed’s Phase II AdrenOSS-2 Trial in Septic Shock

Rentschler Biopharma Achieves ISO 50001 Certification for Energy Management

Formycon and Fresenius Kabi Announce FDA Approval of Interchangeability for FYB202/Otulfi®(ustekinumab-aauz)

PL BioScience and DewCell sign LOI to Jointly Develop Artificial Human Platelets for Scalable, Animal-Free Cell Culture Media

Mainz Biomed Announces Interim Read Out For Its eAArly DETECT 2 Clinical Study

Viromed Medical AG: Revolutionary Cold Plasma Therapy for the Treatment of Ventilator-Associated Pneumonia (VAP) Shows 100% Efficacy in an in vitro Study with MRSA and Human Lung Cells (Alveoli)